# Once-a-day Immunosuppression(CISECON_a_day)

> **NCT01964014** · PHASE4 · COMPLETED · sponsor: **Ajou University School of Medicine** · enrollment: 160 (actual)

## Conditions studied

- Chronic Renal Disease

## Interventions

- **DRUG:** advagrf

## Key facts

- **NCT ID:** NCT01964014
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2016-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964014, "Once-a-day Immunosuppression(CISECON_a_day)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01964014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*